![]() |
|
|
Vol. 29, Issue 4, 401-406, April 2001
Veterans Affairs Medical Center, Division of Geriatric Medicine
(T.V.Z., V.M.L., B.B.D.) and Department of Biochemistry (T.V.Z.), St.
Louis University School of Medicine, St. Louis, Missouri; and
Department of Medicine, Washington University, St. Louis, Missouri
(F.F.H.)
Aromatic amine sulfinamide adducts of hemoglobin are biomarkers of
exposure and evidence for cytochrome P-450
N-hydroxylation. The possible peroxidatic formation of
an N-acetylbenzidine (ABZ) sulfinamide adduct by
methemoglobin was examined. Following addition of
H2O2, 0.06 mM [3H]ABZ was
metabolized by methemoglobin. With 0.3 mM glutathione, a new peak was
observed, ABZ-SG, representing 17% of the total radioactivity.
N'-Hydroxy-N-acetylbenzidine and
4'-nitro-4-acetylaminobiphenyl were not detected. Optimal ABZ-SG
formation was observed with 3 uM methemoglobin, 0.1 to 0.3 mM
glutathione, and pH 5.5. Higher concentrations of glutathione were
inhibitory. Without glutathione, an H2O2-to-ABZ
molar ratio of 1:1 resulted in complete metabolism of ABZ. This ratio
increased to greater than 2:1 with 0.3 mM glutathione. Nearly complete
inhibition of ABZ-SG formation by cyanide (10 mM), ascorbic acid (0.1 mM), 5,5-dimethyl-1-pyrroline N-oxide (50 mM),
thiourea (1 mM), and azide (0.3 mM), and the lack of inhibition by
mannitol (50 mM) and superoxide dismutase (2 µg) is consistent with a
methemoglobin-mediated peroxidatic reaction, which does not involve
hydroxyl radical or superoxide. ABZ-SG was identified by electrospray
ionization/mass spectrometry as N'-(glutathion-S-yl)-N-acetylbenzidine
S-oxide. Conjugate was hydrolyzed by 0.1 N HCl and NaOH,
was relatively stable at pH 5.5 and 7.4, and was susceptible to
-glutamyltranspeptidase treatment. Formation of an ABZ sulfinamide
conjugate with hemoglobin was demonstrated. The results demonstrate
that methemoglobin can catalyze the peroxidatic formation of an ABZ
sulfinamide adduct, perhaps by a diimine monocation intermediate.